International Shipholding Corp. (ISH) is Trading Lower on Unusual Volume for December 21

Equities Staff |

International Shipholding Corp. (ISH) experienced unusually high volume on Dec. 21, as the stock lost 10.99% to a closing price of $1.62. The stock saw 110,780 shares trade hands over the course of the day on 368 trades. Given that the stock’s average daily volume over the last month has been 71,006 shares a day, this represents a pretty substantial spike over the norm.

International Shipholding Corp. has a P/B ratio of 0.05. The stock has traded between $17.44 and $1.57 over the last 52-weeks, its 50-day SMA is now $2.19, and its 200-day SMA $6.31.

International Shipholding Corp operates a fleet of U.S. and International Flag vessels that provide international and domestic maritime transportation services to commercial and governmental customers under medium to long-term contracts.

Headquartered in Mobile, AL, International Shipholding Corp. has 593 employees and is currently under the leadership of CEO Niels M. Johnsen.

For a complete fundamental analysis analysis of International Shipholding Corp., check out Equities.com’s Stock Valuation Analysis report for ISH. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…